The TGA’s SAS enables health practitioners to ... Findings confirmed that Spontan achieves rapid absorption and faster onset of action compared to oral PDE5 inhibitors like Vardenafil ...
Known as the OTC-HOPE study, the first-in-human trial will enrol newborn boys aged up to seven months with genetically confirmed neonatal onset OTC ... Administration (TGA). iECURE CEO Joe Truitt ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果